Findings

What do systematic reviews say?

286 questions · 318 findings · 37 reviews · Developmental, Psychosocial and Learning Problems

Sort:Best matchNewest Highest certainty Download CSV

No studies found 53 · 16.7%GRADE not reported 19 · 6%Very low 84 · 26.4%Low 96 · 30.2%Moderate 60 · 18.9%High 6 · 1.9%

Tricyclic antidepressants vs placebo

Efficacy for ADHD symptoms (teachers using a rating scale) ‐ desipramine · Children and adolescents with ADHD

1 finding from 1 review

Tricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in children and adolescents 2014 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 89 participants
Low

Tricyclic antidepressants vs placebo

CGI (response rate) ‐ desipramine and nortriptyline · Children and adolescents with ADHD

Tricyclic antidepressants (TCAs) may leads to higher CGI (response rate) ‐ desipramine and nortriptyline compared with placebo (low certainty).

1 finding from 1 review

Tricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in children and adolescents 2014 · Cochrane Headline outcomes only
OR 18.5 [6.29, 54.39]
3 studies · 125 participants
Low

Tricyclic antidepressants vs placebo

Clinical global impression (response rate) ‐ desipramine · Children and adolescents with ADHD

Tricyclic antidepressants (TCAs) may leads to higher clinical global impression (response rate) ‐ desipramine compared with placebo (low certainty).

1 finding from 1 review

Tricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in children and adolescents 2014 · Cochrane Headline outcomes only
OR 26.41 [7.41, 94.18]
2 studies · 103 participants
Low

Tricyclic antidepressants vs placebo

All‐cause treatment discontinuation ‐ desipramine · Children and adolescents with ADHD

1 finding from 1 review

Tricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in children and adolescents 2014 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 134 participants
Very low

Iron therapy vs placebo

Bayley Scale PDI within 30 days of commencement of therapy · children less than 3 years of age with iron deficiency anaemia

1 finding from 1 review

Iron therapy for improving psychomotor development and cognitive function in children under the age of three with iron… 2013 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 162 participants
Low

Iron therapy vs placebo

Bayley Scale MDI within 30 days of commencement of therapy · children less than 3 years of age with iron deficiency anaemia

1 finding from 1 review

Iron therapy for improving psychomotor development and cognitive function in children under the age of three with iron… 2013 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 164 participants
Low

Iron therapy vs placebo

Bayley Scale PDI more than 30 days of commencement of therapy · children less than 3 years of age with iron deficiency anaemia

1 finding from 1 review

Iron therapy for improving psychomotor development and cognitive function in children under the age of three with iron… 2013 · Cochrane Headline outcomes only
no estimate extracted
1 study · 47 participants
Moderate

Iron therapy vs placebo

Bayley Scale MDI more than 30 days of commencement of therapy · children less than 3 years of age with iron deficiency anaemia

1 finding from 1 review

Iron therapy for improving psychomotor development and cognitive function in children under the age of three with iron… 2013 · Cochrane Headline outcomes only
no estimate extracted
1 study · 47 participants
Moderate

Iron therapy vs placebo

Denver Developmental Screening Test more than 30 days of commencement of therapy · children less than 3 years of age with iron deficiency anaemia

1 finding from 1 review

Iron therapy for improving psychomotor development and cognitive function in children under the age of three with iron… 2013 · Cochrane Headline outcomes only
no estimate extracted
1 study · 97 participants
Moderate

Supplementary feeding vs no food supplementation or placebo

Weight‐for‐length/height z‐score at the end of the intervention Weight scale, measurement boards and child growth reference · Children aged less than five years with or without stunting/wasting in LMIC

1 finding from 1 review

Community‐based supplementary feeding for promoting the growth of children under five years of age in low and middle… 2012 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 260 participants
Moderate

Supplementary feeding vs no food supplementation or placebo

Mean weight‐for‐age z‐score · Children aged less than five years in LMIC

2 findings from 1 review

Community‐based supplementary feeding for promoting the growth of children under five years of age in low and middle… 2012 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 308 participants
Moderate
Community‐based supplementary feeding for promoting the growth of children under five years of age in low and middle… 2012 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 308 participants
Moderate

Supplementary feeding vs no food supplementation or placebo

Mean height‐for‐age z‐score · Children aged less than five years in LMIC

2 findings from 1 review

Community‐based supplementary feeding for promoting the growth of children under five years of age in low and middle… 2012 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 308 participants
Low
Community‐based supplementary feeding for promoting the growth of children under five years of age in low and middle… 2012 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 308 participants
Low

Supplementary feeding vs no food supplementation or placebo

Weight‐for‐length/height z‐score at the end of the intervention Weight scale, measurement boards and child growth reference · Children aged less than five years in LMIC

2 findings from 1 review

Community‐based supplementary feeding for promoting the growth of children under five years of age in low and middle… 2012 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 260 participants
Moderate
Community‐based supplementary feeding for promoting the growth of children under five years of age in low and middle… 2012 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 260 participants
Moderate

Supplementary feeding vs no food supplementation or placebo

Weight gain · Children aged less than five years in LMIC

1 finding from 1 review

Community‐based supplementary feeding for promoting the growth of children under five years of age in low and middle… 2012 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 668 participants
Very low

Supplementary feeding vs no food supplementation or placebo

Height gain (cm) · Children aged less than five years in LMIC

1 finding from 1 review

Community‐based supplementary feeding for promoting the growth of children under five years of age in low and middle… 2012 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 795 participants
Very low

Zinc vs placebo

Mental development index (MDI) at 18 months · infants and children

1 finding from 1 review

Zinc supplementation for mental and motor development in children 2012 · Cochrane Headline outcomes only
no estimate extracted
8 studies · 2134 participants
Moderate

Zinc vs placebo

Psychomotor development · infants and children

1 finding from 1 review

Zinc supplementation for mental and motor development in children 2012 · Cochrane Headline outcomes only
no estimate extracted
8 studies · 2134 participants
Moderate

Zinc vs placebo

Cognitive function · infants and children

The review found no eligible studies for this question.

1 finding from 1 review

Zinc supplementation for mental and motor development in children 2012 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Zinc vs placebo

Intelligence quotient · infants and children

The review found no eligible studies for this question.

1 finding from 1 review

Zinc supplementation for mental and motor development in children 2012 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Zinc vs placebo

Adverse effects · infants and children

The review found no eligible studies for this question.

1 finding from 1 review

Zinc supplementation for mental and motor development in children 2012 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found